Google
MAIA — MAIA BIOTECHNOLOGY INC. (Healthcare >> Biotechnology)
MAIA FAQ
What is MAIA's ROE?
MAIA BIOTECHNOLOGY INC. reports a Return on Equity (ROE) of -87.34%.
What is MAIA's dividend yield?
MAIA BIOTECHNOLOGY INC. offers a dividend yield of 0.00%.
What is MAIA's Deepscope Quality Score?
Deepscope rates MAIA's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MAIA?
Deepscope's AI Timing Score for MAIA is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MAIA belong to?
MAIA BIOTECHNOLOGY INC. is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 1.36
Price
-0.14
(-9.33%)
Day Change
|
|
|---|
MAIA, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 61 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.36 |
| PBV / Sector |
3.13 / 4.63
|
| Earning Per Share | -0.38 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1.30 M
GREAT
|
| Average 1W Daily Value |
3.15 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:51 |
| Symbol | MAIA |
| Name | MAIA BIOTECHNOLOGY INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 60.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 86.95 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 444 West Lake Street, Chicago, IL, United States, 60606
Phone: 312 416 8592
Website: https://maiabiotech.com
Sector: Healthcare >> Biotechnology
Description: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
